{"id":59253,"date":"2026-06-04T22:31:12","date_gmt":"2026-06-04T13:31:12","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4896\/"},"modified":"2026-08-16T13:13:35","modified_gmt":"2026-08-16T04:13:35","slug":"company-4896","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4896\/","title":{"rendered":"K PHARMA INC"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4896","DATE":"2026-01-09","longName":"K Pharma,Inc.","company_name_ja":"","fullTimeEmployees":20,"address":"","phone":"","website":"https:\/\/www.kpharma.co.jp","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":715,"financialCurrency":"","marketCap":8297,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":-916056000,"operatingMargins":0,"NetIncome":-993227000,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-78.489999999999995,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T03:59:18.404934\", \"ticker\": \"4896\", \"ticker_full\": \"4896.T\", \"company_name\": \"K PHARMA INC\", \"analyst_recommendations\": {\"has_data\": true, \"recommendation_key\": \"none\", \"recommendation_mean\": null, \"total_analysts\": null, \"strong_buy\": null, \"buy\": null, \"hold\": null, \"sell\": null, \"strong_sell\": null}, \"target_prices\": {\"has_data\": true, \"current\": 728.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": false}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 66.01, \"institution_pct\": 10.69, \"major_holders\": [{\"label\": \"\", \"value\": 66.01}, {\"label\": \"\", \"value\": 10.69}, {\"label\": \"\", \"value\": 31.45}, {\"label\": \"\", \"value\": 2.0}], \"institutional_holders\": [], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is headquartered in Minato, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-16T02:03:22.787910\", \"ticker\": \"4896\", \"ticker_full\": \"4896.T\", \"company_name\": \"K PHARMA INC\", \"company_info\": {\"name_en\": \"K PHARMA INC\", \"long_name\": \"K Pharma,Inc.\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/www.kpharma.co.jp\", \"employees\": 20, \"country\": \"Japan\", \"city\": \"Minato\", \"address\": \"Tri-Seven Roppongi\", \"description\": \"K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is headquartered in Minato, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 751.0, \"deviation\": 2.13, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 736.04, \"deviation\": 4.21, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 710.15, \"deviation\": 8.01, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 710.22, \"deviation\": 8.0, \"trend\": \"up\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0.0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -916056000.0, \"operating_income_fmt\": \"-\u00a59\u5104\", \"ebit\": -987211000.0, \"ebit_fmt\": \"-\u00a510\u5104\", \"net_income\": -993227000.0, \"net_income_fmt\": \"-\u00a510\u5104\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 2939220000.0, \"total_assets_fmt\": \"\u00a529\u5104\", \"total_equity\": 1265435000.0, \"total_equity_fmt\": \"\u00a513\u5104\", \"total_debt\": 1500000000.0, \"total_debt_fmt\": \"\u00a515\u5104\", \"total_cash\": 2791835000.0, \"total_cash_fmt\": \"\u00a528\u5104\", \"equity_ratio\": 43.05, \"de_ratio\": 1.19, \"current_ratio\": 28.41, \"operating_cf\": -918005000.0, \"operating_cf_fmt\": \"-\u00a59\u5104\", \"investing_cf\": -54683000.0, \"investing_cf_fmt\": \"-\u00a554.7M\", \"financing_cf\": 1496325000.0, \"financing_cf_fmt\": \"\u00a515\u5104\", \"free_cf\": -929191000.0, \"free_cf_fmt\": \"-\u00a59\u5104\", \"net_margin\": 0, \"roe\": -78.49, \"roa\": -33.79}, {\"year\": 2024, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0.0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -836346000.0, \"operating_income_fmt\": \"-\u00a58\u5104\", \"ebit\": -844104000.0, \"ebit_fmt\": \"-\u00a58\u5104\", \"net_income\": -846455000.0, \"net_income_fmt\": \"-\u00a58\u5104\", \"eps\": -72.94, \"operating_margin\": 0, \"total_assets\": 2353073000.0, \"total_assets_fmt\": \"\u00a524\u5104\", \"total_equity\": 2258313000.0, \"total_equity_fmt\": \"\u00a523\u5104\", \"total_debt\": 0.0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2268198000.0, \"total_cash_fmt\": \"\u00a523\u5104\", \"equity_ratio\": 95.97, \"de_ratio\": 0.0, \"current_ratio\": 37.0, \"operating_cf\": -983719000.0, \"operating_cf_fmt\": \"-\u00a510\u5104\", \"investing_cf\": -14490000.0, \"investing_cf_fmt\": \"-\u00a514.5M\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": -998209000.0, \"free_cf_fmt\": \"-\u00a510\u5104\", \"net_margin\": 0, \"roe\": -37.48, \"roa\": -35.97}, {\"year\": 2023, \"revenue\": 1000000000.0, \"revenue_fmt\": \"\u00a510\u5104\", \"gross_profit\": 910000000.0, \"gross_profit_fmt\": \"\u00a59\u5104\", \"operating_income\": 366058000.0, \"operating_income_fmt\": \"\u00a54\u5104\", \"ebit\": 366058000.0, \"ebit_fmt\": \"\u00a54\u5104\", \"net_income\": 260330000.0, \"net_income_fmt\": \"\u00a53\u5104\", \"eps\": 23.07, \"operating_margin\": 36.61, \"total_assets\": 3313902000.0, \"total_assets_fmt\": \"\u00a533\u5104\", \"total_equity\": 3104768000.0, \"total_equity_fmt\": \"\u00a531\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 3266408000.0, \"total_cash_fmt\": \"\u00a533\u5104\", \"equity_ratio\": 93.69, \"de_ratio\": 0.0, \"current_ratio\": 18.54, \"operating_cf\": 454425000.0, \"operating_cf_fmt\": \"\u00a55\u5104\", \"investing_cf\": -11099000.0, \"investing_cf_fmt\": \"-\u00a511.1M\", \"financing_cf\": 1486235000.0, \"financing_cf_fmt\": \"\u00a515\u5104\", \"free_cf\": 444622000.0, \"free_cf_fmt\": \"\u00a54\u5104\", \"net_margin\": 26.03, \"roe\": 8.38, \"roa\": 7.86}, {\"year\": 2022, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0.0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -353772000.0, \"operating_income_fmt\": \"-\u00a54\u5104\", \"ebit\": -353772000.0, \"ebit_fmt\": \"-\u00a54\u5104\", \"net_income\": -392427000.0, \"net_income_fmt\": \"-\u00a54\u5104\", \"eps\": -42.06, \"operating_margin\": 0, \"total_assets\": 1374566000.0, \"total_assets_fmt\": \"\u00a514\u5104\", \"total_equity\": 1336264000.0, \"total_equity_fmt\": \"\u00a513\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 1336847000.0, \"total_cash_fmt\": \"\u00a513\u5104\", \"equity_ratio\": 97.21, \"de_ratio\": 0.0, \"current_ratio\": 40.7, \"operating_cf\": -363482000.0, \"operating_cf_fmt\": \"-\u00a54\u5104\", \"investing_cf\": -32737000.0, \"investing_cf_fmt\": \"-\u00a532.7M\", \"financing_cf\": 1544285000.0, \"financing_cf_fmt\": \"\u00a515\u5104\", \"free_cf\": -393440000.0, \"free_cf_fmt\": \"-\u00a54\u5104\", \"net_margin\": 0, \"roe\": -29.37, \"roa\": -28.55}, {\"year\": 2021, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": -19.79, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-59253","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>K PHARMA INC - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4896\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4896\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4896\/\",\"name\":\"K PHARMA INC - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T13:31:12+00:00\",\"dateModified\":\"2026-08-16T04:13:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4896\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4896\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4896\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"K PHARMA INC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"K PHARMA INC - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4896\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4896\/","url":"https:\/\/japanir.jp\/en\/company\/company-4896\/","name":"K PHARMA INC - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T13:31:12+00:00","dateModified":"2026-08-16T04:13:35+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4896\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4896\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4896\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"K PHARMA INC"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/59253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=59253"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=59253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}